Last Modified: 7/28/2021
Location: FL, PR, USVI
Business: Part A, Part B
CMS updated the status indicator for HCPCS code Q5122 (Injection, pegfilgrastim-apgf, biosimilar, (nyvepris), 0.5 mg) from “E2” to “K” for dates of service between January 1 and March 31. This change was included in the April 2021 IOCE software.
For HCPCS code Q5122, First Coast updated the status indicator to “K” and the January 2021 OPPS payment quarterly rate to $366.89 and the January 2021 OPPS 340B payment rate to $253.48.
First Coast will adjust claims when brought to our attention. If you think your claim was impacted, please contact customer service to request claims with dates of service January 1 through March 31, for HCPCS code Q5122 to be reprocessed.
Current processing issues
For additional assistance regarding the COVID-19 public health emergency (PHE), visit our dedicated coronavirus
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.